Clinical trial
A Real-World Retrospective Cohort Analysis of SMARCA4-Deficient Advanced Lung Cancer
NCT07121387 is registered in ClinicalTrials.gov with Shanghai Pulmonary Hospital, Shanghai, China as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Real-World Retrospective Cohort Analysis of SMARCA4-Deficient Advanced Lung Cancer
- Lead sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2020
- Completion date
- December 17, 2024
- Enrollment
- 221 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
nsclc (advanced non-small cell lung cancer), smarca4-deficient tumor